Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4

出版年份 2015 全文链接

标题

作者

关键词

Chronic, Hepatitis C virus, Genotype 4, Efficacy, Protease inhibitor, Response-guided, Safety, Simeprevir, Sustained virologic response, TMC435 (10/10)

出版物

JOURNAL OF HEPATOLOGY

Volume 62, Issue 5, Pages 1047-1055

出版商

Elsevier BV

发表日期

2015-01-14

DOI

10.1016/j.jhep.2014.12.031

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started